Drugs / Sodium Phosphate Solution
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00322062 Comparator | Apr 2002 → Mar 2003 | — | Norgine | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Phosphate Solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00322062 ↗ |
| Route | Oral | “Each intake of NaP solution has to be preceded and followed by 250ml” NCT00322062 ↗ |